Franklin Resources’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.4M | Buy |
1,803,597
+23,556
| +1% | +$319K | 0.01% | 868 |
|
|
2025
Q1 | $28.3M | Buy |
1,780,041
+34,444
| +2% | +$547K | 0.01% | 796 |
|
|
2024
Q4 | $21.5M | Buy |
1,745,597
+84
| +0% | +$1.03K | 0.01% | 888 |
|
|
2024
Q3 | $23.7M | Buy |
1,745,513
+262,922
| +18% | +$3.57M | 0.01% | 841 |
|
|
2024
Q2 | $17.3M | Buy |
1,482,591
+575,080
| +63% | +$6.73M | 0.01% | 903 |
|
|
2024
Q1 | $11.7M | Buy |
907,511
+208,044
| +30% | +$2.69M | ﹤0.01% | 1021 |
|
|
2023
Q4 | $6.02M | Buy |
699,467
+249,450
| +55% | +$2.15M | ﹤0.01% | 1065 |
|
|
2023
Q3 | $4.28M | Buy |
450,017
+17
| +0% | +$162 | ﹤0.01% | 1134 |
|
|
2023
Q2 | $7.67M | Hold |
450,000
| – | – | ﹤0.01% | 985 |
|
|
2023
Q1 | $7.05M | Buy |
+450,000
| New | +$7.05M | ﹤0.01% | 1011 |
|